课题基金 / 基金详情

Multidisciplinary Research Training in Pediatric Pulmonary Vascular Disease

Multidisciplinary Research Training in Pediatric Pulmonary Vascular Disease
小儿肺血管疾病多学科研究培训
批准号:
10673931
负责人:
Steven Herbert Abman
金额:
$37.63万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-08-01 至 2027-07-31

项目摘要

项目成果

Steven Herbert Abman的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT Pulmonary vascular disease (PVD) is a significant source of morbidity and mortality in neonates, infants and children with diverse heart, lung and systemic diseases. A major barrier to improving outcomes of children with PVD is the fundamental lack of understanding the differing pathobiologies among the spectrum of these disorders, which intersect between multiple clinical disciplines. This is compounded by the scarcity of training opportunities to develop and retain physician-scientists and scientists with expertise in PVD that allows for the successful translation of laboratory and clinical science across multiple disciplines. Thus, there is a need for well-trained scientists in Pediatric PVD who can perform collaborative and rigorous inter-disciplinary investigation to enhance the development of new treatment modalities. This novel application requests the resources to establish a unique two-year post-doctoral collaborative research training program in Pediatric PVD within the Departments of Pediatrics at the University of California, San Francisco, the University of Colorado, and Vanderbilt University. The goal of the program is to increase the number of highly trained, successfully funded and sustainable pediatric pulmonary vascular scientists, who will perform high level laboratory, clinical- translational, and/or health services research that will ultimately improve our understanding of the pathobiology of diverse pediatric PVD, design therapeutic plans that specifically target an individual’s underlying pathobiology, and thereby improve both short and long-term outcomes. To this end, this program aims to provide comprehensive scientific training through novel mentoring and collaborative approaches to enhance career development for physicians or post-doctorate scientists with an M.D., M.D./Ph.D. or Ph.D., who commit themselves to an academic career in pediatric PVD. The key and unique elements of this training program are: (1) a rich, diverse, mentored research experience; (2) interdisciplinary and inter-institutional experiences, including joint didactic learning opportunities, with direct integration into the North American Pediatric Pulmonary Hypertension Network and the associated Annual International Conference; and (3) continuous review and evaluation from academic leaders in the field. The centerpiece of the program for pediatric-scientists is the continuation of a 4-year fellowship training program (including but not limited to Pediatric Cardiology, Critical Care, Emergency Medicine, Neonatology, or Pulmonology), with 2 years devoted to intense research training in basic laboratory science, clinical-translational science, health services or epidemiology related to pediatric PVD. Exceptional faculty have committed their support as mentors, who lead and are affiliated with several of their universities’ research units and clinical programs, a represent a “critical mass” that few single centers can provide. Thus, the rationale for this novel proposal is based on the need for well-designed training programs in Pediatric PVD research, including the need to foster multi-disciplinary and multi-interdisciplinary collaborative approaches, and that these three institutions have the vision, experience, and collaborative infrastructure to train the next generation of leaders.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
Sex differences in endothelial cell function: an evolving explanation of sex differences in preterm infant pulmonary outcomes.
内皮细胞功能的性别差异:早产儿肺部结局性别差异的不断发展的解释。
DOI: 10.1152/ajpheart.00718.2022
发表时间: 2023
期刊: American journal of physiology. Heart and circulatory physiology
影响因子: --
作者: [Cookson,MichaelW, Sherlock,LauraG]
通讯作者: Sherlock,LauraG
DOI: 10.1002/pul2.12108
发表时间: 2022-07
期刊: PULMONARY CIRCULATION
影响因子: 2.6
作者: [Tsoi, Stephanie M., Jones, Kirk, Colglazier, Elizabeth, Parker, Claire, Nawaytou, Hythem, Teitel, David, Fineman, Jeffrey R., Keller, Roberta L.]
通讯作者: Keller, Roberta L.
1/2 Kids MoD PAH Trial: Mono- vs. Duo-Therapy In Pediatric Pulmonary Arterial Hypertension
  • 批准号:
    10214935
  • 项目类别:
  • 资助金额:
    $95.26万
  • 财政年份:
    2021
  • 负责人:
    Steven Herbert Abman
  • 依托单位:
1/2 Kids MoD PAH Trial: Mono- vs. Duo-Therapy In Pediatric Pulmonary Arterial Hypertension
  • 批准号:
    10505262
  • 项目类别:
  • 资助金额:
    $129.89万
  • 财政年份:
    2021
  • 负责人:
    Steven Herbert Abman
  • 依托单位:
Colorado StARR Program in Medicine and Pediatrics (CSPMP)
  • 批准号:
    10671451
  • 项目类别:
  • 资助金额:
    $34.31万
  • 财政年份:
    2020
  • 负责人:
    Steven Herbert Abman
  • 依托单位:
Colorado StARR Program in Medicine and Pediatrics (CSPMP)
  • 批准号:
    10376740
  • 项目类别:
  • 资助金额:
    $34.31万
  • 财政年份:
    2020
  • 负责人:
    Steven Herbert Abman
  • 依托单位:
海外基金